Rocket One (RKTO) Shares Outstanding (2017 - 2026)
Rocket One's (RKTO) quarterly Shares Outstanding (Entity) came in at $23.2 million in Q2 2026, up 75.19% year-over-year from $13.2 million in Q2 2025, and up 42.49% quarter-over-quarter from $16.3 million in Q1 2026.
Analysis
Rocket One (RKTO) Shares Outstanding (2017 - 2026) Analysis & Trends
Rocket One has disclosed Shares Outstanding (Entity) across 10 years of filings, most recently posting $23.2 million for Q2 2026.
- In Q2 2026, Shares Outstanding (Entity) rose 75.19% year-over-year to $23.2 million; the TTM figure through Jun 2026 stood at $23.2 million (up 75.19% YoY), while the FY2025 annual figure was $15.5 million, up 143.36% from the prior year.
- Shares Outstanding (Entity) came in at $23.2 million for Q2 2026 at Rocket One, up from $16.3 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $32.2 million in Q2 2022 to a low of $1.3 million in Q3 2022.
- Average Shares Outstanding (Entity) over 5 years is $10.7 million, with a median of $6.9 million recorded in 2024.
- Year-over-year, Shares Outstanding (Entity) sank 94.63% in 2022 and soared 199.08% in 2025.
- Over 5 years, Shares Outstanding (Entity) stood at $1.3 million in 2022, then jumped by 161.82% to $3.4 million in 2023, then soared by 87.0% to $6.4 million in 2024, then soared by 143.36% to $15.5 million in 2025, then jumped by 49.44% to $23.2 million in 2026.
- Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $23.2 million in Q2 2026, $16.3 million in Q1 2026, and $15.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.77 Bn | 197.79 Bn | 7.24 Bn | 540.00 Mn |
| 2 | Gilead Sciences | 181.13 Bn | 177.95 Bn | 6.22 Bn | 1.24 Bn |
| 3 | Vertex Pharmaceuticals | 132.24 Bn | 124.39 Bn | 2.84 Bn | 253.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.89 Bn | 3.93 Bn | 102.80 Mn |
| 5 | Argenx Se | 61.56 Bn | 56.38 Bn | 1.37 Bn | 61.30 Mn |
| 6 | Moderna | 54.38 Bn | 49.24 Bn | 52.00 Mn | 398.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.44 Bn | 31.13 Bn | 992.69 Mn | 133.61 Mn |
| 8 | Biogen | 31.17 Bn | 29.89 Bn | 1.96 Bn | 147.70 Mn |
| 9 | Roivant Sciences | 30.12 Bn | 30.12 Bn | 1.16 Mn | 720.78 Mn |
| 10 | Rocket One | 13.80 Mn | 5.90 Mn | - | 20.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.55 Mn |
| Mar 31, 2026 | 15.79 Mn |
| Dec 31, 2025 | 13.81 Mn |
| Sep 30, 2025 | 13.79 Mn |
| Jun 30, 2025 | 13.18 Mn |
| Mar 31, 2025 | 12.73 Mn |
| Dec 31, 2024 | 6.38 Mn |
| Sep 30, 2024 | 6.90 Mn |
| Jun 30, 2024 | 6.88 Mn |
| Mar 31, 2024 | 4.40 Mn |
| Dec 31, 2023 | 3.41 Mn |
| Sep 30, 2023 | 3.48 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | 2.48 Mn |
| Dec 31, 2022 | 1.20 Mn |
| Sep 30, 2022 | 1.29 Mn |
| Jun 30, 2022 | 31.03 Mn |
| Mar 31, 2022 | 23.97 Mn |
| Dec 31, 2021 | 22.33 Mn |
| Sep 30, 2021 | 23.89 Mn |